The New York Times

A.I. Is Writing Fiction. Publishers Are Unprepared.

Book publishing has few safeguards in place to prevent the unwitting publication of a novel heavily generated by artificial intelligence. By Alexandra Alter For months, speculation has been building ...
WFMZ-TV

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...
Taiwan News

BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on ...

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE)-- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by ...
ascopubs.org

Global Approach to Oncology Leadership: The GOLD Program

Leadership is essential for addressing global challenges in cancer care. Equipped with leadership skills, health care providers can respond effectively to complex oncology issues in diverse settings, ...
Reuters

China approves market launch of brain-computer interface medical device in world first

HONG KONG, March 13 (Reuters) - China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system that helps restore hand-movement ability to be sold, the ...